Hospital morbidity due to anabolic-androgenic steroids (AAS) consumption in Brazil

Hospital morbidity due to anabolic-androgenic steroids (AAS) consumption in Brazil / Sérgio Henrique Almeida da Silva Junior. - (Revista Brasileira de Medicina do Esporte 19 (2013|) 2 (March/April); p. 108-111)

  • DOI: 10.1590/S1517-86922013000200007


INTRODUCTION: Anabolic androgenic steroids (AAS) are male sex hormones, developers and maintainers of sexual characteristics associated with masculinity and the anabolic status of somatic tissues. The physical and mental effects of AAS abuse are rare and it is almost impossible to say with certainty what adverse effects may become evident after their self-administration; however, they constitute risk of death for the individuals.

OBJECTIVE: The aim of this study was to describe the main characteristics of morbidity by AAS ingestion in Brazil in the 2000/2010 period.

METHODS: Information on hospitalizations was obtained from computerized databases of the Ministry of Health. In the analysis of AAS consumption as primary or secondary diagnosis for hospital admission, the E28.1 (androgen excess), E34.5 (androgen insensitivity syndrome), T38.7 (adverse effect of and underdosing of androgens and anabolic congeners) and Y42.7 (adverse effects in the therapeutic use of androgens and anabolic congeners) codes of the ICD-10 were used.

RESULTS: Hospitalizations by AAS were responsible for 0.001% of total admissions in the country. 1,319 admissions (mean = 119.9, SD = 99.01) were accounted. The Androgen insensitivity syndrome was the primary cause, corresponding to 55.8% of total admissions. Of of all hospitalizations, 1% of patients died and the maximum stay was of 47 days (mean = 3.8, SD = 4.7). Minas Gerais, Maranhão and Espírito Santo presented the highest rates of hospital admissions per 1,000,000 inhabitants from 2002 to 2007. Women and people aged 15-29 presented the highest hospitalization rate 82.5% and 37.7%, respectively.

CONCLUSION: The results of this study showed that the hospitalization rate was relatively low for AAS intake; women and individuals aged 15-29 years possessed the highest rates in the period studied.

Original document


Research / Study
1 April 2013
Silva Junior, Sérgio Henrique Almeida da
Other organisations
Escola Nacional Saúde Pública Sergio Arouca (ENSP)- National School of Public Health Sergio Arouca
Doping classes
S1. Anabolic Agents
Medical terms
Health effects
Legitimate Medical Treatment
Document type
Pdf file
Date generated
5 November 2020
Date of last modification
6 November 2020
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period